In the last years, several clinical studies have shown a positive correlation between enhanced visfatin plasma levels and endothelial dysfunction [5]–[9], while in particular clinical conditions such as renal transplantation, plasma visfatin has been even identified as a strong predictor of FMD both before and after transplantation [11]. Here, NAMPT is linked to endothelial dysfunction.